Skip to main content
TipRanks
Go Ultimate75% OFF

Reckon Health Care Holdings Ltd (GGR) AI Stock Analysis

0 Followers
AU:GGR

Reckon Health Care Holdings Ltd

(ASX:GGR)

Select Model
Rating:44Neutral
Price Target:AUD 0.18â–²(9.37% Upside)
Action:reiterated
Date:10/07/26

The low overall score is driven primarily by very weak financial performance, with minimal revenue, persistent losses, and significant cash burn funded by equity. Secondary pressure comes from a mildly bearish technical picture, while the absence of a supportive valuation (negative P/E and no dividend) reinforces the stock’s speculative, early-stage profile.

Positive Factors
Low LeverageZero total debt in 2026 and modest leverage in other years reduce interest and refinancing pressure. This gives the company greater financial flexibility than a highly indebted peer, although that advantage is tempered by continued losses and the need to fund operations.
Negative Factors
Pre-Revenue PositionA largely pre-revenue operating profile indicates the company has not yet demonstrated durable commercial traction. Without meaningful recurring revenue, fixed costs and development spending are harder to absorb, while future operations remain dependent on achieving substantial revenue conversion.

Reckon Health Care Holdings Ltd (GGR) vs. iShares MSCI Australia ETF (EWA)

-25%0%25%50%75%100%125%150%AU:GGR+14.29%EWA+17.02%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
AUD 22.40M
Dividend Yield
―
Average Volume (3M)
27.18K
Price to Earnings (P/E)
-6.2
Beta (1Y)
0.43
Revenue Growth
―
EPS Growth
-24.03%
Country
Australia
Employees
1
Sector
General
Sector Strength
55
Industry
Other Precious Metals

Reckon Health Care Holdings Ltd Business Overview & Revenue Model

Company Description

Golden Globe Resources Ltd. (GGR.AX) is an Australian mineral exploration company focused on discovering and developing copper and gold resources. The firm maintains full ownership of the Dooloo Creek Project, which includes two exploration permits s...

Reckon Health Care Holdings Ltd Financial Statement Overview

Summary

Financial performance is weak, with negligible revenue, persistent and worsening losses, and consistently negative operating and free cash flow, partially offset by a low-leverage balance sheet supported by fresh equity.

Income Statement

12Very Negative

Balance Sheet

60Neutral

Cash Flow

20Very Negative
Financial statement breakdown
BreakdownTTMJun 2026Dec 2024Jun 2024Jun 2023Jun 2022
Income Statement
Total Revenue75.10K0007,6360
Gross Profit75.10K-685007,6360
EBITDA-2.10M-2.10M00-1.20M-1.20M
Net Income-2.23M-2.23M-1.81M-1.16M-1.39M-1.49M
Balance Sheet
Total Assets8.48M8.48M2.55M2.35M2.96M3.69M
Cash, Cash Equivalents and Short-Term Investments3.55M3.55M261.65K1,361189.50K1.07M
Total Debt00389.86K253.00K037.50K
Total Liabilities517.89K517.89K1.38M678.14K205.41K119.17K
Stockholders Equity7.96M7.96M1.18M1.67M2.75M3.57M
Cash Flow
Free Cash Flow-4.48M-2.12M-546.49K-479.95K-1.28M-1.71M
Operating Cash Flow-3.17M-2.11M-482.67K-373.72K-1.08M-1.16M
Investing Cash Flow-3.89M-2.60M-47.70K110.08K-329.26K-557.37K
Financing Cash Flow12.00M8.00M790.65K75.50K530.73K1.68M

Reckon Health Care Holdings Ltd Technical Analysis

Technical Analysis SentimentPositive
Last Price0.16

Price Trends

50DMA0.15Positive
100DMA0.15Positive
200DMA0.21Negative

Market Momentum

MACD0.00Negative
RSI57.60Neutral
STOCH33.33Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:GGR, the sentiment is Positive. The current price of 0.16 is above the 20-day moving average (MA) of 0.15, above the 50-day MA of 0.15, and below the 200-day MA of 0.21, indicating a neutral trend. The MACD of 0.00 indicates Negative momentum. The RSI at 57.60 is Neutral, neither overbought nor oversold. The STOCH value of 33.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:GGR.

Reckon Health Care Holdings Ltd Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

AU:GGR against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
AU:GGRAU:GGR44NeutralAUD 22.40M-6.20-26.92%――-24.03%
AU:EIQAU:EIQ37UnderperformAUD 366.73M-17.37-128.49%―-9.28%-25.66%

* General Sector Average

Performance Comparison

0%200%400%600%AU:GGRAU:EIQDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
AU:GGR and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
AU:GGRReckon Health Care Holdings Ltd0.160.016.67%
AU:EIQEchoIQ Limited0.490.28125.00%

Reckon Health Care Holdings Ltd Corporate Events

Golden Globe Resources Updates Market on Director Raymond Raad’s Final Interests After Board Exit

Oct 30, 2026

Golden Globe Resources Ltd has announced that director Raymond Raad ceased to be a director on 29 October 2026, triggering an update to the ASX on his final interests in the company’s securities. The notice outlines his direct holding of 4,750,000 op...

Golden Globe Resources Appoints New Director With No Initial Shareholdings

Oct 30, 2026

Golden Globe Resources Ltd has announced the appointment of Mark Andrew Licciardo as a director, effective 29 October 2026, and has lodged an initial director’s interest notice with the ASX. The filing confirms that Licciardo currently holds no relev...

Golden Globe Resources Flags Strong Copper Results and Advances Alma Exploration

Oct 29, 2026

Golden Globe Resources reported encouraging early exploration results at the historic Burns Spur copper mine within the Dooloo Creek Project in Queensland. Rock-chip sampling returned high copper grades with associated gold and silver, reinforcing th...

Golden Globe Resources Reshapes Board After AGM Voting Upset

Oct 29, 2026

Golden Globe Resources reported the results of its annual general meeting, confirming that shareholders approved the adoption of the remuneration report while rejecting the re-election of non-executive director Raymond Raad and the proposal for an ad...

Golden Globe ramps up copper-gold exploration at Alma project in Mt Morgan district

Oct 27, 2026

Golden Globe Resources has initiated field exploration at its Alma copper-gold project in Queensland’s Mount Morgan district, a historically prolific region that produced substantial gold and copper. The project covers a large, underexplored landhold...

Golden Globe Resources Pulls Share Placement Resolution Ahead of AGM

Oct 27, 2026

Golden Globe Resources Ltd has withdrawn Resolution 4 from its upcoming Annual General Meeting scheduled for 29 October 2026. The resolution concerned approval to issue placement shares, and any votes already lodged on this item will now be disregard...

Golden Globe Resources Rectifies Late Director Interest Disclosures

Oct 8, 2026

Golden Globe Resources has disclosed that it failed to lodge initial director interest notices for three board members at the time of its admission to the ASX, attributing the omission to an administrative oversight. The company has now submitted the...

Golden Globe Resources Sets Date and Digital Framework for 2026 AGM

Sep 30, 2026

Golden Globe Resources Limited has convened its 2026 Annual General Meeting for 29 October 2026 at 11:00 a.m. AEDT, to be held in person at a North Sydney venue, with meeting materials available online via the company’s website and ASX platform. The...

Golden Globe Resources lodges ASX corporate governance statement for FY2026

Sep 23, 2026

Golden Globe Resources Limited has lodged its corporate governance statement and accompanying Appendix 4G with the ASX for the financial year ended 30 June 2026, confirming compliance with disclosure requirements under Listing Rules 4.7.3 and 4.10.3....

Golden Globe Resources Files 2026 Annual Report

Sep 23, 2026

Golden Globe Resources Limited has released its annual report for the year ended 30 June 2026, detailing the consolidated financial performance, position and cash flows of the group. The report, authorised by the board on 23 September 2026, underscor...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 07, 2026